World's Best Scientists 2026 revealed!
Philip S. Helliwell

Philip S. Helliwell

D-Index & Metrics

Medicine

D-Index
83
Citations
32242
World Ranking
15433
National Ranking
1419

Philip S. Helliwell publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philip S. Helliwell sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 516 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Philip S. Helliwell D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philip S. Helliwell sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Philip S. Helliwell is affiliated with the University of Leeds in the United Kingdom. Their research focuses primarily on Medicine and Immunology and Microbiology, with significant contributions in the subfields of Rheumatology, Immunology, Hematology, Economics and Econometrics, and Dermatology. The scientist's main research topics include Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis, Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research, Health Systems, Economic Evaluations, Quality of Life, Dermatology and Skin Diseases, and Osteomyelitis and Bone Disorders Research.

Helliwell has contributed extensively to academic literature, with a significant number of publications appearing in a range of specialist venues. Frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • The Journal of Rheumatology
  • RMD Open
  • Journal of the American Academy of Dermatology

The researcher has collaborated often with colleagues such as Laura C. Coates, Philip J. Mease, Dafna D. Gladman, Oliver FitzGerald, and A. Kollmeier.

Among recent papers associated with the scientist are:

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021, 2022, Nature Reviews Rheumatology
  • Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial, 2020, The Lancet
  • Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials, 2020, Annals of the Rheumatic Diseases
  • Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies, 2021, The Lancet Rheumatology
  • Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced, 2021, RMD Open

Best Publications

  • Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

    William Taylor;Dafna Gladman;Philip Helliwell;Antonio Marchesoni

  • Correction: Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis

    John Bowes;Ashley Budu-Aggrey;Ulrike Huffmeier;Steffen Uebe

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Josef S Smolen;Monika Schöls;Jürgen Braun;Maxime Dougados

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

  • Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment

    Laura C Coates;Jaap Fransen;Philip S Helliwell

  • Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

    L C Doward;A Spoorenberg;S A Cook;D Whalley

  • Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

    Josef S. Smolen;Jürgen Braun;Maxime Dougados;Paul Emery

  • European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

    L Gossec;J S Smolen;C Gaujoux-Viala;Z Ash

  • Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis.

    Paul J. Healy;Philip S. Helliwell

  • Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

    Laura C Coates;Anna R Moverley;Lucy McParland;Sarah Brown

  • A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    Laure Gossec;Maarten de Wit;Uta Kiltz;Juergen Braun

  • Classification and diagnostic criteria for psoriatic arthritis.

    P S Helliwell;W J Taylor

  • The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

    Philip S Helliwell;Philip S Helliwell;Oliver FitzGerald;Jaap Fransen;Dafna D Gladman

  • Consensus on a core set of domains for psoriatic arthritis

    Dafna D Gladman;Philip J Mease;Vibeke Strand;Paul Healy

  • Comparison of disability and quality of life in rheumatoid and psoriatic arthritis.

    Katharina B. Sokoll;Philip S. Helliwell

  • Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire.

    G H Ibrahim;M H Buch;C Lawson;R Waxman

  • A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

    Philip J Mease;Josef S Smolen;Frank Behrens;Peter Nash

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

    Laura C Coates;Oliver Fitzgerald;Joseph F Merola;Josef Smolen

Frequent Co-Authors

Philip J. Mease
Philip J. Mease University of Washington
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Oliver FitzGerald
Oliver FitzGerald University College Dublin
Neil McHugh
Neil McHugh University of Bath
Paul Emery
Paul Emery University of Leeds
Christopher T. Ritchlin
Christopher T. Ritchlin University of Rochester Medical Center
Arthur Kavanaugh
Arthur Kavanaugh University of California, San Diego
Dennis McGonagle
Dennis McGonagle University of Leeds
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Wolf-Henning Boehncke
Wolf-Henning Boehncke University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine isn’t the only path to a healthcare career in the USA—related online degrees can open doors to a variety of fast-growing fields. For those interested in pharmacy, recent innovations now make it possible to complete a 3 year online pharmd, blending flexible study with advanced clinical training.

Medical administration also offers a strong career outlook. Many students now pursue rhia certification programs online to qualify for roles managing health information systems and ensuring data accuracy.

For those seeking quick entry into healthcare, exploring the cheapest medical coding certification online can start your career in medical billing and coding—a vital function in hospitals and clinics.

Nursing remains a cornerstone of patient care, and students can advance their credentials through cheap online fnp programs to become family nurse practitioners. These online pathways make it easier for diverse students to access rewarding careers in healthcare beyond traditional medicine.

Best Scientists Citing Philip S. Helliwell

Trending Scientists

Recently Published Articles